A phase 2 trial suggests that the novel SNRI ammoxetine may effectively treat major depressive disorder while avoiding some ...
A new study published in the journal Psychiatric Services reports that three major artificial intelligence chatbots perform ...
Clinical Trials Arena on MSN
Trials to watch: Three major catalysts in Alzheimer’s disease
While Lilly and Eisai/Biogen have validated the amyloid theory, there is an unmet need for drugs with alternative mechanisms ...
Patients reported a significant reduction in pain scores in the months after starting the cannabis extract, which is not the ...
What’s next: By the end of June, the watchdog had an inventory of 2,294 complaints that had yet to be determined. Maynard ...
The Royal Devon University Healthcare NHS Foundation Trust and the University of Exeter have launched the RAPID-IBD study to speed up diagnosis o ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback